V
VRTX
StockHealth CareVertex Pharmaceuticals Incorporated Common Stock
$496.83
+$16.70 (+3.48%)
Price Chart
No chart data available
About Vertex Pharmaceuticals Incorporated Common Stock
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.
Market cap
$98.23B
Company information
ExchangeNASDAQ
CountryUnited States of America
CEOJeffrey M Leiden
Employees2,300
Frequently Asked Questions About VRTX
The current price of Vertex Pharmaceuticals Incorporated Common Stock (VRTX) stock is $496.83 USD. The stock has changed +3.48% in today's trading session.
You can buy VRTX stock through Wallbit, available in 80+ countries worldwide. Simply create an account, fund it, and you can start investing in Vertex Pharmaceuticals Incorporated Common Stock and thousands of other US stocks.
Vertex Pharmaceuticals Incorporated Common Stock (VRTX) has a market capitalization of $98.23B. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.
Vertex Pharmaceuticals Incorporated Common Stock (VRTX) operates in the Health Care sector. This classification helps investors understand the company's primary business activities and compare it with similar companies.
The current CEO of Vertex Pharmaceuticals Incorporated Common Stock (VRTX) is Jeffrey M Leiden. The CEO is responsible for the company's overall strategic direction and day-to-day operations.
Vertex Pharmaceuticals Incorporated Common Stock (VRTX) has approximately 2,300 employees worldwide.
Vertex Pharmaceuticals Incorporated Common Stock (VRTX) is listed on the NASDAQ. Trading hours are typically Monday through Friday, 9:30 AM to 4:00 PM Eastern Time.